Technology · Biotechnology R&D expenditure
The Republic of the Congo's expenditure on biotechnology research and development in 2026 is 1 $ — ranking 153 out of 197 countries. Lack of investment is due to the priority of the oil sector, which accounts for most of GDP. Biotechnology in Congo is undeveloped: no major laboratories, no government support programs, and scientific personnel are concentrated at universities in Brazzaville operating on minimal funding.
Data for 2026 · unit: $
Position
#153 / 197
Republic of the Congo world ranking
Country position on the scale from last to first place for this indicator.
CG
#153
#197#1
Trend
Change over time
Change in indicator over the available period.
0
1990
1
2000
1
2010
3
2020
1
2025
1
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where Republic of the Congo stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in Republic of the Congo — how much?
Based on 2026 data — 1 $. This is rank #153 out of 197 countries.
What is Republic of the Congo's rank by Biotechnology R&D expenditure?
Republic of the Congo ranks #153 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Republic of the Congo?
Over the available period the indicator changed from 0 to 1 $.